Jacobs Levy Equity Management’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-16,210
| Closed | -$454K | – | 1007 |
|
|
2023
Q4 | $454K | Buy |
+16,210
| New | +$454K | ﹤0.01% | 845 |
|
|
2022
Q3 | – | Sell |
-23,756
| Closed | -$1.63M | – | 1104 |
|
|
2022
Q2 | $1.63M | Sell |
23,756
-23,251
| -49% | -$1.6M | 0.01% | 649 |
|
|
2022
Q1 | $6.69M | Sell |
47,007
-17,508
| -27% | -$2.49M | 0.05% | 365 |
|
|
2021
Q4 | $10.7M | Buy |
+64,515
| New | +$10.7M | 0.07% | 287 |
|
|
2020
Q4 | – | Sell |
-1,141
| Closed | -$646K | – | 1062 |
|
|
2020
Q3 | $646K | Sell |
1,141
-10,624
| -90% | -$6.01M | 0.01% | 741 |
|
|
2020
Q2 | $1.12M | Buy |
11,765
+1,146
| +11% | +$109K | 0.01% | 649 |
|
|
2020
Q1 | $758K | Sell |
10,619
-6,051
| -36% | -$432K | 0.01% | 687 |
|
|
2019
Q4 | $1.15M | Buy |
16,670
+8,813
| +112% | +$608K | 0.01% | 668 |
|
|
2019
Q3 | $630K | Buy |
7,857
+4,243
| +117% | +$340K | 0.01% | 688 |
|
|
2019
Q2 | $233K | Sell |
3,614
-6,205
| -63% | -$400K | ﹤0.01% | 853 |
|
|
2019
Q1 | $1.35M | Buy |
9,819
+2,815
| +40% | +$387K | 0.02% | 596 |
|
|
2018
Q4 | $633K | Buy |
7,004
+490
| +8% | +$44.3K | 0.01% | 697 |
|
|
2018
Q3 | $989K | Sell |
6,514
-460
| -7% | -$69.8K | 0.01% | 650 |
|
|
2018
Q2 | $1.2M | Buy |
6,974
+2,540
| +57% | +$437K | 0.02% | 618 |
|
|
2018
Q1 | $651K | Sell |
4,434
-27
| -0.6% | -$3.96K | 0.01% | 730 |
|
|
2017
Q4 | $905K | Buy |
+4,461
| New | +$905K | 0.02% | 634 |
|